<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer</journal-id><journal-id journal-id-type="iso-abbrev">Cancer</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Cancer</journal-title></journal-title-group><issn pub-type="ppub">0008-543X</issn><issn pub-type="epub">1097-0142</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10664461</article-id><article-id pub-id-type="pmcid-ver">PMC10664461.1</article-id><article-id pub-id-type="pmcaid">10664461</article-id><article-id pub-id-type="pmcaiid">10664461</article-id><article-id pub-id-type="manuscript-id">NIHMS1829735</article-id><article-id pub-id-type="pmid">35599575</article-id><article-id pub-id-type="doi">10.1002/cncr.34238</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1829735</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1829735</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>New persistent opioid use among adolescents and young adults with sarcoma</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4058-1586</contrib-id><name name-style="western"><surname>Beauchemin</surname><given-names initials="MP">Melissa P.</given-names></name><degrees>PhD, MSN, CPNP</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Raghunathan</surname><given-names initials="RR">Rohit R.</given-names></name><degrees>MS</degrees><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Accordino</surname><given-names initials="MK">Melissa K.</given-names></name><degrees>MD, MS</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-4036-7838</contrib-id><name name-style="western"><surname>Cogan</surname><given-names initials="JC">Jacob C.</given-names></name><degrees>MD</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="A4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3330-6754</contrib-id><name name-style="western"><surname>Kahn</surname><given-names initials="JM">Justine M.</given-names></name><degrees>MD, MS</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wright</surname><given-names initials="JD">Jason D.</given-names></name><degrees>MD</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="A5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-8807-153X</contrib-id><name name-style="western"><surname>Hershman</surname><given-names initials="DL">Dawn L.</given-names></name><degrees>MD, MS</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="A4" ref-type="aff">4</xref></contrib></contrib-group><aff id="A1"><label>1</label>School of Nursing, Columbia University Irving Medical Center, New York, New York</aff><aff id="A2"><label>2</label>Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York</aff><aff id="A3"><label>3</label>Division of Pediatric Hematology/Oncology/Stem Cell Transplantation, Department of Pediatrics, Columbia University Irving Medical Center, New York, New York</aff><aff id="A4"><label>4</label>Division of Hematology/Oncology, Department of Medicine, Columbia University Irving Medical Center, New York, New York</aff><aff id="A5"><label>5</label>Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Columbia University Irving Medical Center, New York, New York</aff><author-notes><fn fn-type="con" id="FN1"><p id="P1">AUTHOR CONTRIBUTIONS</p><p id="P2"><bold>Melissa P. Beauchemin:</bold>Study conception and design, material preparation, data collection and analysis, drafting of the manuscript, commentary on previous versions of the manuscript, and approval of the final version of the manuscript. <bold>Rohit R. Raghunathan:</bold> Study conception and design, material preparation, data collection and analysis, commentary on previous versions of the manuscript, and approval of the final version of the manuscript. <bold>Melissa K. Accordino:</bold> Study conception and design, commentary on previous versions of the manuscript, and approval of the final version of the manuscript. <bold>Jacob C. Cogan:</bold> Study conception and design, commentary on previous versions of the manuscript, and approval of the final version of the manuscript. <bold>Justine M. Kahn:</bold> Study conception and design, commentary on previous versions of the manuscript, and approval of the final version of the manuscript. <bold>Jason D. Wright:</bold> Study conception and design, commentary on previous versions of the manuscript, and approval of the final version of the manuscript. <bold>Dawn L. Hershman:</bold> Study conception and design, material preparation, data collection and analysis, commentary on previous versions of the manuscript, and approval of the final version of the manuscript.</p></fn><corresp id="CR1"><bold>Corresponding Author:</bold> Melissa P. Beauchemin, PhD, MSN, CPNP, Columbia University Mailman School of Nursing, 560 W 168th St 634, New York, NY 10032 (<email>mmp2123@cumc.columbia.edu</email>).</corresp><fn fn-type="COI-statement" id="FN2"><p id="P36">CONFLICT OF INTEREST DISCLOSURES</p><p id="P37">Jason D. Wright reports support from Merck and royalties from UpToDate. The other authors made no disclosures.</p></fn></author-notes><pub-date pub-type="ppub"><day>15</day><month>7</month><year>2022</year></pub-date><pub-date pub-type="epub"><day>23</day><month>5</month><year>2022</year></pub-date><volume>128</volume><issue>14</issue><issue-id pub-id-type="pmc-issue-id">449562</issue-id><fpage>2777</fpage><lpage>2785</lpage><pub-history><event event-type="nihms-submitted"><date><day>15</day><month>11</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>22</day><month>11</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>22</day><month>11</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-15 16:25:15.287"><day>15</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1829735.pdf"/><abstract id="ABS1"><sec id="S1"><title>BACKGROUND:</title><p id="P3">Adolescents and young adults (AYA) with sarcoma experience both acute and chronic pain related to their disease and treatment. Studies in older adults have reported a high risk of persistent opioid use after cancer therapy among previously opioid-naive patients; however, few studies have evaluated posttreatment opioid use among AYAs. This article describes patterns of new persistent opioid use among AYAs in the year after treatment for sarcoma.</p></sec><sec id="S2"><title>METHODS:</title><p id="P4">Opioid-naive patients who were 10 to 26 years old and diagnosed with sarcoma (2008&#8211;2 016) were identified with the IBM Marketscan Database. Included subjects had an <italic toggle="yes">International Classification of Diseases</italic> code for sarcoma (ninth or tenth revision), received anticancer therapy (chemotherapy, surgery, and/or radiation) within 30 days of the first diagnosis code, and had continuous insurance coverage (commercial or Medicaid) for more than 12 months both before the diagnosis and after the last therapy. The primary outcome was new persistent opioid use, which was defined as at least 2 opioid prescriptions in the 12 months following treatment completion. Covariates included age, sex, insurance, tumor type, surgical procedure, mental health (MH) or substance use diagnoses before or during therapy, and concomitant lorazepam use.</p></sec><sec id="S3"><title>RESULTS:</title><p id="P5">In total, 938 patients met the inclusion criteria; 521 (56%) were male, and 578 (62%) were younger than 18 years. In total, 727 (78%) had commercial insurance, and 273 (29%) had an MH diagnosis either before or during the treatment period. Of the total group, 464 (49%) used opioids during treatment only. Of those who used opioids during treatment, 135 (23%) received at least 2 prescriptions in the year after therapy. In a multivariable analysis, Medicaid versus commercial insurance (odds ratio [OR], 1.74; 95% confidence interval [CI], 1.15&#8211;2.64) and non&#8211;soft tissue sarcoma (OR for Ewing sarcoma, 3.23; 95% CI, 1.81&#8211;5 .78; OR for osteosarcoma, 2.05; 95% CI, 1.36&#8211; 3.09) conferred a higher likelihood of new persistent use.</p></sec><sec id="S4"><title>CONCLUSIONS:</title><p id="P6">In this cohort of AYAs treated for sarcoma, 64% of the patients received opioid prescriptions during treatment, and 23% of these patients became new persistent users. Because of the risks associated with persistent opioid use, studies of novel pain management strategies along with age-appropriate education and anticipatory guidance are urgently needed.</p></sec></abstract><kwd-group><kwd>adolescent</kwd><kwd>cancer</kwd><kwd>cancer pain</kwd><kwd>opioid-related disorders</kwd><kwd>young adult</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>